This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.

This brief highlights issues specific to Asian American, Native Hawaiian, and Pacific Islander males. It provides clinicians with data on the prevalence of depression, suicide, and substance use disorders within these populations.